Loading...
Loading...
India's atorvastatin imports from BRAZIL total $14.8K across 15 shipments from 12 foreign suppliers. DERMA & DERMO COM.PRODS, DERM, FARM, LTDA(AMHO) leads with $3.9K in import value; the top 5 suppliers together control 81.0% of this origin. Leading Indian buyers include LAMBDA THERAPEUTIC RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for atorvastatin — a diversified sourcing base with multiple active suppliers from BRAZIL.

DERMA & DERMO COM.PRODS, DERM, FARM, LTDA(AMHO) is the leading Atorvastatin supplier from BRAZIL to India, with import value of $3.9K across 1 shipments. The top 5 suppliers — DERMA & DERMO COM.PRODS, DERM, FARM, LTDA(AMHO), DERMA & DERMO COM.PRODS.DERM.FARM., PHARMACEUTICAL BUYERS INC, SUN FARMACEUTICA DO BRASIL LTDA., SUN PARMACEUTICA DO BRASIL LTDA — collectively account for 81.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DERMA & DERMO COM.PRODS, DERM, FARM, LTDA(AMHO) | $3.9K | 1 | 26.5% |
| 2 | DERMA & DERMO COM.PRODS.DERM.FARM. | $2.4K | 1 | 15.9% |
| 3 | PHARMACEUTICAL BUYERS INC | $2.2K | 1 | 15.0% |
| 4 | SUN FARMACEUTICA DO BRASIL LTDA. | $1.9K | 1 | 13.1% |
| 5 | SUN PARMACEUTICA DO BRASIL LTDA | $1.5K | 2 | 10.5% |
| 6 | SUN FARMACEUTICA DO BRASIL LTDA | $1.4K | 1 | 9.2% |
| 7 | T&E Analitica Centro Cientifico | $509 | 1 | 3.4% |
| 8 | DERMA & DERMO COM. PRODS. DERM | $333 | 3 | 2.3% |
| 9 | WEP CLINICAL | $281 | 1 | 1.9% |
| 10 | DR. REDDYS FARMACEUTICA DO BRASIL LTDA | $169 | 1 | 1.1% |
| 11 | INOVA COMERCIO IMPORTACAO E EXPORTACAO LTDA | $158 | 1 | 1.1% |
| 12 | PHARMACEUTICAL BUYERS, INC. | $0 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $3.9K | 1 | 26.5% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $3.5K | 3 | 23.6% |
| 3 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $3.0K | 3 | 20.4% |
| 4 | ACCUTEST RESEARCH LABORATORIES INDIA PRIVATE LIMIT | $2.4K | 1 | 15.9% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LTD | $1.4K | 1 | 9.2% |
| 6 | CYMA LIFE SCIENCES PRIVATE LIMITED | $333 | 3 | 2.3% |
| 7 | DR.REDDY'S LABORATORIES LTD | $169 | 1 | 1.1% |
| 8 | ZENRISE CLINICAL RESEARCH PRIVATE LIMITED | $158 | 1 | 1.1% |
| 9 | MYLAN LABORATORIES LIMITED | $0 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Atorvastatin suppliers from BRAZIL to India include DERMA & DERMO COM.PRODS, DERM, FARM, LTDA(AMHO), DERMA & DERMO COM.PRODS.DERM.FARM., PHARMACEUTICAL BUYERS INC. The leading supplier is DERMA & DERMO COM.PRODS, DERM, FARM, LTDA(AMHO) with import value of $3.9K USD across 1 shipments. India imported Atorvastatin worth $14.8K USD from BRAZIL in total across 15 shipments.
India imported Atorvastatin worth $14.8K USD from BRAZIL across 15 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Atorvastatin sourced from BRAZIL include LAMBDA THERAPEUTIC RESEARCH LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED. The largest buyer is LAMBDA THERAPEUTIC RESEARCH LIMITED with $3.9K in imports across 1 shipments.
The total value of Atorvastatin imports from BRAZIL to India is $14.8K USD, across 15 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15 Verified Shipments
12 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists